IRIS
D'ALESSANDRO, MIRIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.030
NA - Nord America 13.386
AS - Asia 7.449
SA - Sud America 1.289
Continente sconosciuto - Info sul continente non disponibili 854
AF - Africa 497
OC - Oceania 25
AN - Antartide 1
Totale 37.531
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.015
IT - Italia 4.342
RU - Federazione Russa 3.249
SG - Singapore 2.457
CN - Cina 1.680
IE - Irlanda 1.562
GB - Regno Unito 1.385
BR - Brasile 1.046
VN - Vietnam 946
DE - Germania 831
HK - Hong Kong 760
SE - Svezia 661
FR - Francia 614
FI - Finlandia 480
IN - India 364
KR - Corea 289
ZA - Sudafrica 241
BD - Bangladesh 229
NL - Olanda 212
CA - Canada 198
ES - Italia 143
UA - Ucraina 118
JP - Giappone 113
IQ - Iraq 96
MX - Messico 91
PL - Polonia 86
CZ - Repubblica Ceca 74
CI - Costa d'Avorio 70
TR - Turchia 66
AR - Argentina 65
AT - Austria 54
PK - Pakistan 48
ID - Indonesia 45
EC - Ecuador 43
EG - Egitto 41
IR - Iran 41
NG - Nigeria 39
CH - Svizzera 34
KE - Kenya 33
UZ - Uzbekistan 33
MA - Marocco 32
SA - Arabia Saudita 32
VE - Venezuela 31
AE - Emirati Arabi Uniti 30
PH - Filippine 30
CL - Cile 28
CO - Colombia 24
MY - Malesia 22
AU - Australia 20
IL - Israele 20
JO - Giordania 20
BE - Belgio 19
LT - Lituania 18
PE - Perù 18
PT - Portogallo 17
JM - Giamaica 16
BG - Bulgaria 14
KZ - Kazakistan 14
NP - Nepal 14
RO - Romania 14
TN - Tunisia 14
CR - Costa Rica 13
HU - Ungheria 13
PY - Paraguay 13
AZ - Azerbaigian 12
GR - Grecia 12
EE - Estonia 11
LV - Lettonia 11
OM - Oman 10
PA - Panama 10
BO - Bolivia 9
KG - Kirghizistan 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
GE - Georgia 8
LB - Libano 8
UY - Uruguay 8
AL - Albania 7
DZ - Algeria 7
LK - Sri Lanka 7
MK - Macedonia 7
NO - Norvegia 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
CY - Cipro 6
ET - Etiopia 6
EU - Europa 6
QA - Qatar 6
GT - Guatemala 5
PS - Palestinian Territory 5
SN - Senegal 5
SV - El Salvador 5
TH - Thailandia 5
AM - Armenia 4
LA - Repubblica Popolare Democratica del Laos 4
MD - Moldavia 4
TW - Taiwan 4
BH - Bahrain 3
BS - Bahamas 3
GY - Guiana 3
Totale 36.626
Salva come PNG Salva come JPEG
Città #
Dallas 2.681
Singapore 1.533
Dublin 1.531
San Jose 1.112
Ashburn 1.055
Southend 1.040
Moscow 989
Santa Clara 907
Milan 830
Hong Kong 704
Chandler 621
Council Bluffs 544
Fairfield 461
Hefei 429
Siena 427
Beijing 419
Los Angeles 412
Munich 374
Lastra a Signa 363
Helsinki 321
New York 301
Rome 300
Ho Chi Minh City 289
Seoul 279
Florence 254
Hanoi 242
Johannesburg 220
Lauterbourg 213
Houston 204
Seattle 193
Wilmington 192
Woodbridge 183
Princeton 180
The Dalles 153
Cambridge 147
São Paulo 115
Chicago 107
Ann Arbor 100
Columbus 97
Shanghai 97
Buffalo 94
Bengaluru 93
Orem 81
Tokyo 79
Frankfurt am Main 78
Lappeenranta 73
Warsaw 73
Abidjan 70
London 70
Nuremberg 69
Turku 69
Redondo Beach 67
Fremont 66
Turin 60
Figino 58
Düsseldorf 57
Málaga 57
Boardman 56
Portsmouth 55
San Mateo 55
Chennai 54
Jacksonville 54
Da Nang 53
Toronto 52
Phoenix 49
San Diego 48
Naples 47
Boston 45
Montreal 45
Brooklyn 44
Dong Ket 44
Haiphong 44
Stockholm 44
Washington 44
Atlanta 43
Amsterdam 39
Brno 39
Denver 39
Baghdad 38
Bologna 36
Manchester 35
Poplar 35
Abuja 33
Brescia 33
San Francisco 31
Newark 30
Paris 30
Rio de Janeiro 30
Tashkent 30
Mumbai 29
Olomouc 28
Vienna 28
Charlotte 27
Mexico City 27
Miami 25
Salt Lake City 25
Cagliari 24
Dhaka 23
New Delhi 23
Zurich 22
Totale 23.468
Salva come PNG Salva come JPEG
Nome #
A first update on mapping the human genetic architecture of COVID-19 605
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 594
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 512
Genetic mechanisms of critical illness in COVID-19 454
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 442
An explainable model of host genetic interactions linked to COVID-19 severity 390
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 387
Pathogen-sugar interactions revealed by universal saturation transfer analysis 375
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 370
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 357
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 335
Mapping the human genetic architecture of COVID-19 328
Peripheral biomarkers' panel for severe COVID-19 patients 325
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 320
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 315
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 310
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 306
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 304
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 301
Antithrombin III as predictive indicator of survival in IPF patients treated with Nintedanib: a preliminary study 294
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 289
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 288
A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting 277
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 271
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 267
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 267
Prognostic bioindicators in severe COVID-19 patients 259
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 258
Serial KL-6 measurements in COVID-19 patients 256
A real-life experience with ImmunoCAP ISAC: the advantages of a new diagnostic method 253
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab 250
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 250
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 246
BAL Proteomic Signature of Lung Adenocarcinoma in IPF Patients and Its Transposition in Serum Samples for Less Invasive Diagnostic Procedures 244
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 240
Alveolar nitric oxide as a biomarker of COVID-19 lung sequelae: A pivotal study 240
Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases 237
NK and NKT-like cells in granulomatous and fibrotic lung diseases 235
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 235
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 234
Altered serum concentrations of IL-8, IL-32 and IL-10 in patients with lung impairment 6 months after COVID-19 232
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 232
BAL biomarkers’ panel for differential diagnosis of interstitial lung diseases 231
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 230
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 229
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy 229
BAL and serum multiplex lipid profiling in idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis 229
A multicenter approach to evaluate omalizumab effectiveness in Samter’s triad 226
Whole-genome sequencing reveals host factors underlying critical COVID-19 222
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 221
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 220
Inflammatory muscle involvement in systemic vasculitis: A systematic review 219
WES profiling of COVID-19 218
Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence 217
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 214
Serum amyloid A: A potential biomarker of lung disorders 212
Clinical and molecular characterization of COVID-19 hospitalized patients 211
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 208
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 207
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist 206
Alteration of Immune-checkpoint after specific stimulation with CMV antigens in pre-LTx patients 206
Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes 205
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 204
Protective role of a TMPRSS2 variant on severe COVID-19 outcome in young males and elderly women 203
Right cardiac involvement in lung diseases: a multimodality approach from diagnosis to prognostication 202
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 202
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review 201
Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution 201
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 200
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases 198
Effects of rituximab therapy on B cell differentiation and depletion 198
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 196
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 193
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab 192
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis 191
Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study 189
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 189
CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients 189
Proteomic characterization of idiopathic pulmonary fibrosis patients: stable versus acute exacerbation 189
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis? 189
Krebs von den Lungen-6 as biomarker for disease severity assessment in interstitial lung disease: a comprehensive review 189
Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant 187
Prognostic role of KL-6 in lymphangioleiomyomatosis patients 186
Differential redox proteomic profiles of serum from severe asthma patients after one month of Benralizumab and Mepolizumab treatment 186
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 186
The Effects of Interstitial Lung Diseases on Alveolar Extracellular Vesicles Profile: A Multicenter Study 184
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 184
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 184
Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker? 183
Bronchoalveolar-Lavage-Derived Fibroblast Cell Line (B-LSDM7) as a new protocol for investigating the mechanisms of idiopathic pulmonary fibrosis 182
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 181
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases 178
Sarcoid Nodule or Lung Cancer? A High-Resolution Computed Tomography-Based Retrospective Study of Pulmonary Nodules in Patients with Sarcoidosis 175
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective 174
Immunologic responses to antifibrotic treatment in IPF patients 173
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of Interstitial Lung Disease 171
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis 168
Specificity of serum amyloid A as a biomarker of idiopathic pulmonary fibrosis 167
Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review 167
Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers: BALF features in asbestos exposed workers 166
Totale 24.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.772 0 0 194 146 106 100 87 109 96 286 231 417
2022/20232.800 181 305 334 279 157 479 308 236 176 138 121 86
2023/20243.278 121 95 325 187 177 689 908 166 50 115 135 310
2024/20257.553 629 300 842 417 853 452 416 440 588 364 687 1.565
2025/202617.763 1.173 2.244 2.104 2.064 3.393 645 2.196 539 640 971 630 1.164
2026/20271.569 704 490 375 0 0 0 0 0 0 0 0 0
Totale 37.531